These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 11521750

  • 1. Extended treatment with typical and atypical antipsychotic drugs differential effects on the densities of dopamine D2-like and GABAA receptors in rat striatum.
    Dean B, Hussain T, Scarr E, Pavey G, Copolov DL.
    Life Sci; 2001 Aug 03; 69(11):1257-68. PubMed ID: 11521750
    [Abstract] [Full Text] [Related]

  • 2. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ, Tarazi FI, Creese I.
    J Pharmacol Exp Ther; 1997 Feb 03; 280(2):561-9. PubMed ID: 9023264
    [Abstract] [Full Text] [Related]

  • 3. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
    Tarazi FI, Florijn WJ, Creese I.
    Neuroscience; 1997 Jun 03; 78(4):985-96. PubMed ID: 9174067
    [Abstract] [Full Text] [Related]

  • 4. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
    Markianos M, Hatzimanolis J, Lykouras L.
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun 03; 251(3):141-6. PubMed ID: 11697576
    [Abstract] [Full Text] [Related]

  • 5. Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study.
    Bigliani V, Mulligan RS, Acton PD, Ohlsen RI, Pike VW, Ell PJ, Gacinovic S, Kerwin RW, Pilowsky LS.
    Psychopharmacology (Berl); 2000 Jun 03; 150(2):132-40. PubMed ID: 10907666
    [Abstract] [Full Text] [Related]

  • 6. Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.
    Pilowsky LS, Busatto GF, Taylor M, Costa DC, Sharma T, Sigmundsson T, Ell PJ, Nohria V, Kerwin RW.
    Psychopharmacology (Berl); 1996 Mar 03; 124(1-2):148-53. PubMed ID: 8935810
    [Abstract] [Full Text] [Related]

  • 7. Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions.
    Radke JM, Owens MJ, Ritchie JC, Nemeroff CB.
    Proc Natl Acad Sci U S A; 1998 Sep 15; 95(19):11462-4. PubMed ID: 9736759
    [Abstract] [Full Text] [Related]

  • 8. In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol.
    Tauscher J, Küfferle B, Asenbaum S, Fischer P, Pezawas L, Barnas C, Tauscher-Wisniewski S, Brücke T, Kasper S.
    Psychopharmacology (Berl); 1999 Jan 15; 141(2):175-81. PubMed ID: 9952042
    [Abstract] [Full Text] [Related]

  • 9. Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways.
    Sakai K, Gao XM, Hashimoto T, Tamminga CA.
    Synapse; 2001 Feb 15; 39(2):152-60. PubMed ID: 11180502
    [Abstract] [Full Text] [Related]

  • 10. Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptors.
    Farnbach-Pralong D, Bradbury R, Copolov D, Dean B.
    Eur J Pharmacol; 1998 May 22; 349(2-3):R7-8. PubMed ID: 9671088
    [Abstract] [Full Text] [Related]

  • 11. Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint.
    Bernardo M, Parellada E, Lomeña F, Catafau AM, Font M, Gómez JC, López-Carrero C, Gutiérrez F, Pavía J, Salamero M.
    Psychiatry Res; 2001 Aug 25; 107(2):87-97. PubMed ID: 11530275
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex.
    Damask SP, Bovenkerk KA, de la Pena G, Hoversten KM, Peters DB, Valentine AM, Meador-Woodruff JH.
    Brain Res Mol Brain Res; 1996 Sep 05; 41(1-2):241-9. PubMed ID: 8883957
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the new atypical antipsychotics olanzapine and ICI 204,636 with clozapine on behavioural responses to the selective "D1-like" dopamine receptor agonist A 68930 and selective "D2-like" agonist RU 24213.
    Deveney AM, Waddington JL.
    Psychopharmacology (Berl); 1996 Mar 05; 124(1-2):40-9. PubMed ID: 8935799
    [Abstract] [Full Text] [Related]

  • 14. Differential in vivo inhibition of [3H]nemonapride binding by atypical antipsychotics in rat striatum, olfactory lobes, and frontal cortex.
    Assié MB, Consul-Denjean N, Koek W, Newman-Tancredi A.
    Pharmacology; 2005 Oct 05; 75(2):63-8. PubMed ID: 16020947
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression.
    Zink M, Schmitt A, May B, Müller B, Demirakca T, Braus DF, Henn FA.
    Schizophr Res; 2004 Feb 01; 66(2-3):151-7. PubMed ID: 15061247
    [Abstract] [Full Text] [Related]

  • 16. Subchronic treatment with either clozapine, olanzapine or haloperidol produces a hyposensitive response of the rat cortical cells to N-methyl-D-aspartate.
    Jardemark KE, Liang X, Arvanov V, Wang RY.
    Neuroscience; 2000 Feb 01; 100(1):1-9. PubMed ID: 10996453
    [Abstract] [Full Text] [Related]

  • 17. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex.
    Gessa GL, Devoto P, Diana M, Flore G, Melis M, Pistis M.
    Neuropsychopharmacology; 2000 Jun 01; 22(6):642-9. PubMed ID: 10788763
    [Abstract] [Full Text] [Related]

  • 18. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs.
    Lidow MS, Goldman-Rakic PS.
    J Pharmacol Exp Ther; 1997 Nov 01; 283(2):939-46. PubMed ID: 9353417
    [Abstract] [Full Text] [Related]

  • 19. Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: homogenate binding and autoradiographic studies.
    Huang N, Ase AR, Hébert C, van Gelder NM, Reader TA.
    Neurochem Int; 1997 Mar 01; 30(3):277-90. PubMed ID: 9041559
    [Abstract] [Full Text] [Related]

  • 20. Comparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D2 receptor occupancy in schizophrenia.
    Paquet F, Soucy JP, Stip E, Lévesque M, Elie A, Bédard MA.
    J Neuropsychiatry Clin Neurosci; 2004 Mar 01; 16(1):47-56. PubMed ID: 14990759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.